how do glp 1 agonists work Top GLP-1 Balance Weight Loss Efficacy, Safety GLP-1 Agonist-based Therapies: An Emerging
Description
1 Introduction The success and ever increasing interest in incretin-based therapies and drugs especially sitagliptin, vildagliptin and exenatide depict their immense importance in improving patient outcomes in T2DM (Nasr and Sadek, 2022)
People switching from other GLP-1 agonists Switching from semaglutide or tirzepatide to retatrutide is increasingly common as people seek greater weight loss results
GLP-1 receptor agonists have demonstrated significant anti-inflammatory properties in the central nervous system
Pharmacotherapy should be considered for patients with BMI 30 kg/m or BMI 27 kg/m with weight-related comorbidities who have not achieved goals with lifestyle modification alone
Examples of GLP-1 receptor agonists licensed in the UK include semaglutide, dulaglutide, liraglutide, exenatide and lixisenatide
Roncaglioni, M
